111 related articles for article (PubMed ID: 27082859)
1. Optic Pathway Gliomas: Clinical Manifestation, Treatment, and Follow-Up.
Ertiaei A; Hanaei S; Habibi Z; Moradi E; Nejat F
Pediatr Neurosurg; 2016; 51(5):223-8. PubMed ID: 27082859
[TBL] [Abstract][Full Text] [Related]
2. Clinical Presentation and Outcome of Patients With Optic Pathway Glioma.
Robert-Boire V; Rosca L; Samson Y; Ospina LH; Perreault S
Pediatr Neurol; 2017 Oct; 75():55-60. PubMed ID: 28847625
[TBL] [Abstract][Full Text] [Related]
3. Treatment and Outcome in 65 Children with Optic Pathway Gliomas.
El Beltagy MA; Reda M; Enayet A; Zaghloul MS; Awad M; Zekri W; Taha H; El-Khateeb N
World Neurosurg; 2016 May; 89():525-34. PubMed ID: 26898488
[TBL] [Abstract][Full Text] [Related]
4. Optic pathway gliomas in adults.
Shofty B; Constantini S; Bokstein F; Ram Z; Ben-Sira L; Freedman S; Vainer G; Kesler A
Neurosurgery; 2014 Mar; 74(3):273-9; discussion 279-80. PubMed ID: 24335817
[TBL] [Abstract][Full Text] [Related]
5. Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature.
Friedrich RE; Nuding MA
Anticancer Res; 2016 Aug; 36(8):4095-121. PubMed ID: 27466519
[TBL] [Abstract][Full Text] [Related]
6. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.
Segal L; Darvish-Zargar M; Dilenge ME; Ortenberg J; Polomeno RC
J AAPOS; 2010 Apr; 14(2):155-8. PubMed ID: 20451859
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal measures of visual function, tumor volume, and prediction of visual outcomes after treatment of optic pathway gliomas.
Kelly JP; Leary S; Khanna P; Weiss AH
Ophthalmology; 2012 Jun; 119(6):1231-7. PubMed ID: 22364864
[TBL] [Abstract][Full Text] [Related]
8. Orbital optic nerve gliomas in children with neurofibromatosis type 1.
Zeid JL; Charrow J; Sandu M; Goldman S; Listernick R
J AAPOS; 2006 Dec; 10(6):534-9. PubMed ID: 17189147
[TBL] [Abstract][Full Text] [Related]
9. Optic glioma warranting treatment in children.
Kaufman LM; Doroftei O
Eye (Lond); 2006 Oct; 20(10):1149-64. PubMed ID: 17019413
[TBL] [Abstract][Full Text] [Related]
10. Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program.
Dalla Via P; Opocher E; Pinello ML; Calderone M; Viscardi E; Clementi M; Battistella PA; Laverda AM; Da Dalt L; Perilongo G
Neuro Oncol; 2007 Oct; 9(4):430-7. PubMed ID: 17704361
[TBL] [Abstract][Full Text] [Related]
11. Visual outcome following chemotherapy for progressive optic pathway gliomas.
Shofty B; Ben-Sira L; Freedman S; Yalon M; Dvir R; Weintraub M; Toledano H; Constantini S; Kesler A
Pediatr Blood Cancer; 2011 Sep; 57(3):481-5. PubMed ID: 21241008
[TBL] [Abstract][Full Text] [Related]
12. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
Gnekow AK; Kortmann RD; Pietsch T; Emser A
Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
[TBL] [Abstract][Full Text] [Related]
13. Treatment of optic pathway hypothalamic gliomas in childhood: experience with 18 consecutive cases.
Jaing TH; Lin KL; Tsay PK; Hsueh C; Hung PC; Wu CT; Tseng CK
J Pediatr Hematol Oncol; 2008 Mar; 30(3):222-4. PubMed ID: 18376285
[TBL] [Abstract][Full Text] [Related]
14. Application of diffusion tensor tractography in pediatric optic pathway glioma.
Lober RM; Guzman R; Cheshier SH; Fredrick DR; Edwards MS; Yeom KW
J Neurosurg Pediatr; 2012 Oct; 10(4):273-80. PubMed ID: 22900485
[TBL] [Abstract][Full Text] [Related]
15. Pediatric Optic Pathway Gliomas: A Report From Northern Greece.
Panagopoulou P; Athanasiadis D; Αnastasiou Α; Zafeiriou D; Papakonstantinou Ε
J Pediatr Hematol Oncol; 2023 Nov; 45(8):445-451. PubMed ID: 37696004
[TBL] [Abstract][Full Text] [Related]
16. Isolated optic nerve gliomas: a multicenter historical cohort study.
Shofty B; Ben-Sira L; Kesler A; Jallo G; Groves ML; Iyer RR; Lassaletta A; Tabori U; Bouffet E; Thomale UW; Hernáiz Driever P; Constantini S;
J Neurosurg Pediatr; 2017 Dec; 20(6):549-555. PubMed ID: 28984541
[TBL] [Abstract][Full Text] [Related]
17. [Characteristics of primary ocular symptoms in children with optic pathway glioma at different ages].
Mijiti G; Shi W; Li L; Yu JF; Ge M; Yan HG; Peng CX
Zhonghua Yan Ke Za Zhi; 2023 May; 59(5):376-380. PubMed ID: 37151006
[No Abstract] [Full Text] [Related]
18. Follow-up of optic pathway gliomas in children with neurofibromatosis type 1.
Kuenzle C; Weissert M; Roulet E; Bode H; Schefer S; Huisman T; Landau K; Boltshauser E
Neuropediatrics; 1994 Dec; 25(6):295-300. PubMed ID: 7770126
[TBL] [Abstract][Full Text] [Related]
19. Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients.
Thiagalingam S; Flaherty M; Billson F; North K
Ophthalmology; 2004 Mar; 111(3):568-77. PubMed ID: 15019338
[TBL] [Abstract][Full Text] [Related]
20. Optic pathway glioma: long-term visual outcome in children without neurofibromatosis type-1.
Campagna M; Opocher E; Viscardi E; Calderone M; Severino SM; Cermakova I; Perilongo G
Pediatr Blood Cancer; 2010 Dec; 55(6):1083-8. PubMed ID: 20979170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
